BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20978486)

  • 1. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.
    Dellon ES; Chen X; Miller CR; Fritchie KJ; Rubinas TC; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2011 Feb; 106(2):264-71. PubMed ID: 20978486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.
    Dellon ES; Chen X; Miller CR; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2012 Oct; 107(10):1503-11. PubMed ID: 22777338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
    Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms.
    Kutty GR; Downs-Kelly E; Crispin HT; Peterson KA
    Dig Dis Sci; 2019 Jan; 64(1):152-157. PubMed ID: 30267171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAST CELLS DISTINGUISH EOSINOPHILIC ESOPHAGITIS IN PEDIATRIC PATIENTS.
    Lomazi EA; Brandalise NA; Servidoni MFPC; Cardoso SR; Meirelles LR
    Arq Gastroenterol; 2017; 54(3):192-196. PubMed ID: 28492714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.
    Mulder DJ; Mak N; Hurlbut DJ; Justinich CJ
    Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study.
    Dellon ES; Rusin S; Gebhart JH; Covey S; Speck O; Woodward K; Higgins LL; Beitia R; Madanick RD; Levinson S; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2015 Sep; 110(9):1347-54. PubMed ID: 26303128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis.
    Kanamori A; Tanaka F; Takashima S; Sawada A; Ominami M; Nadatani Y; Fukunaga S; Otani K; Hosomi S; Kamata N; Nagami Y; Taira K; Watanabe T; Fujiwara Y
    Esophagus; 2023 Apr; 20(2):333-341. PubMed ID: 36342564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of ALOX15 expression with eosinophilic or reflux esophagitis in a cohort of pediatric patients with esophageal eosinophilia.
    Matoso A; Allen D; Herzlinger M; Ferreira J; Chen S; Lu S; Fabre V; Monahan R; Yang D; Noble L; Mangray S; Resnick MB
    Hum Pathol; 2014 Jun; 45(6):1205-12. PubMed ID: 24742828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features distinguish eosinophilic and reflux-induced esophagitis.
    Mulder DJ; Hurlbut DJ; Noble AJ; Justinich CJ
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):263-70. PubMed ID: 23085895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis.
    García-Rojo M; Sánchez J; de la Santa E; Durán E; Ruiz JL; Silva A; Rubio FJ; Rodríguez AM; Meléndez B; González L; López-Viedma B
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S7. PubMed ID: 25565117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders.
    Patel DA; Higginbotham T; Slaughter JC; Aslam M; Yuksel E; Katzka D; Gyawali CP; Mashi M; Pandolfino J; Vaezi MF
    Gastroenterology; 2019 May; 156(6):1617-1626.e1. PubMed ID: 30711626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.
    Dellon ES; Gibbs WB; Fritchie KJ; Rubinas TC; Wilson LA; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1305-13; quiz 1261. PubMed ID: 19733260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.
    Martin LJ; Franciosi JP; Collins MH; Abonia JP; Lee JJ; Hommel KA; Varni JW; Grotjan JT; Eby M; He H; Marsolo K; Putnam PE; Garza JM; Kaul A; Wen T; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jun; 135(6):1519-28.e8. PubMed ID: 26051952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image Analysis of Eosinophil Peroxidase Immunohistochemistry for Diagnosis of Eosinophilic Esophagitis.
    Wright BL; Doyle AD; Shim KP; Pai RK; Barshow SM; Horsley-Silva JL; Luo H; Rank MA; Jacobsen EA; Katzka DA; Kita H; Dellon ES
    Dig Dis Sci; 2021 Mar; 66(3):775-783. PubMed ID: 32248390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial.
    Dellon ES; Woosley JT; McGee SJ; Moist SE; Shaheen NJ
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 32193541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased number of regulatory T cells in esophageal tissue of patients with eosinophilic esophagitis in comparison to gastro esophageal reflux disease and control groups.
    Mousavinasab F; Babaie D; Nilipour Y; Mansouri M; Imanzadeh F; Dara N; Rohani P; Khatami K; Sayyari A; Khoddami M; Kazemiaghdam M; Mesdaghi M
    Allergol Immunopathol (Madr); 2019; 47(5):431-436. PubMed ID: 31178311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
    Otani IM; Anilkumar AA; Newbury RO; Bhagat M; Beppu LY; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2013 Jun; 131(6):1576-82. PubMed ID: 23623266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
    Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
    J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.